Copyright Reports & Markets. All rights reserved.

Global Laboratory Developed Tests (LDT) Market 2025 by Company, Regions, Type and Application, Forecast to 2031

Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of Laboratory Developed Tests (LDT) by Type
    • 1.3.1 Overview: Global Laboratory Developed Tests (LDT) Market Size by Type: 2020 Versus 2024 Versus 2031
    • 1.3.2 Global Laboratory Developed Tests (LDT) Consumption Value Market Share by Type in 2024
    • 1.3.3 Clinical Biochemistry
    • 1.3.4 Hematology
    • 1.3.5 Immunology
    • 1.3.6 Molecular Diagnostics
    • 1.3.7 Other
  • 1.4 Global Laboratory Developed Tests (LDT) Market by Application
    • 1.4.1 Overview: Global Laboratory Developed Tests (LDT) Market Size by Application: 2020 Versus 2024 Versus 2031
    • 1.4.2 Hospitals Laboratory
    • 1.4.3 Clinical Research Organizations
    • 1.4.4 Academic Institutes
    • 1.4.5 Specialty Diagnostic Centers
    • 1.4.6 Other
  • 1.5 Global Laboratory Developed Tests (LDT) Market Size & Forecast
  • 1.6 Global Laboratory Developed Tests (LDT) Market Size and Forecast by Region
    • 1.6.1 Global Laboratory Developed Tests (LDT) Market Size by Region: 2020 VS 2024 VS 2031
    • 1.6.2 Global Laboratory Developed Tests (LDT) Market Size by Region, (2020-2031)
    • 1.6.3 North America Laboratory Developed Tests (LDT) Market Size and Prospect (2020-2031)
    • 1.6.4 Europe Laboratory Developed Tests (LDT) Market Size and Prospect (2020-2031)
    • 1.6.5 Asia-Pacific Laboratory Developed Tests (LDT) Market Size and Prospect (2020-2031)
    • 1.6.6 South America Laboratory Developed Tests (LDT) Market Size and Prospect (2020-2031)
    • 1.6.7 Middle East & Africa Laboratory Developed Tests (LDT) Market Size and Prospect (2020-2031)

2 Company Profiles

  • 2.1 Quest Diagnostics
    • 2.1.1 Quest Diagnostics Details
    • 2.1.2 Quest Diagnostics Major Business
    • 2.1.3 Quest Diagnostics Laboratory Developed Tests (LDT) Product and Solutions
    • 2.1.4 Quest Diagnostics Laboratory Developed Tests (LDT) Revenue, Gross Margin and Market Share (2020-2025)
    • 2.1.5 Quest Diagnostics Recent Developments and Future Plans
  • 2.2 Thermo Fisher
    • 2.2.1 Thermo Fisher Details
    • 2.2.2 Thermo Fisher Major Business
    • 2.2.3 Thermo Fisher Laboratory Developed Tests (LDT) Product and Solutions
    • 2.2.4 Thermo Fisher Laboratory Developed Tests (LDT) Revenue, Gross Margin and Market Share (2020-2025)
    • 2.2.5 Thermo Fisher Recent Developments and Future Plans
  • 2.3 Waters Corporation
    • 2.3.1 Waters Corporation Details
    • 2.3.2 Waters Corporation Major Business
    • 2.3.3 Waters Corporation Laboratory Developed Tests (LDT) Product and Solutions
    • 2.3.4 Waters Corporation Laboratory Developed Tests (LDT) Revenue, Gross Margin and Market Share (2020-2025)
    • 2.3.5 Waters Corporation Recent Developments and Future Plans
  • 2.4 Roche
    • 2.4.1 Roche Details
    • 2.4.2 Roche Major Business
    • 2.4.3 Roche Laboratory Developed Tests (LDT) Product and Solutions
    • 2.4.4 Roche Laboratory Developed Tests (LDT) Revenue, Gross Margin and Market Share (2020-2025)
    • 2.4.5 Roche Recent Developments and Future Plans
  • 2.5 Illumina
    • 2.5.1 Illumina Details
    • 2.5.2 Illumina Major Business
    • 2.5.3 Illumina Laboratory Developed Tests (LDT) Product and Solutions
    • 2.5.4 Illumina Laboratory Developed Tests (LDT) Revenue, Gross Margin and Market Share (2020-2025)
    • 2.5.5 Illumina Recent Developments and Future Plans
  • 2.6 Qiagen
    • 2.6.1 Qiagen Details
    • 2.6.2 Qiagen Major Business
    • 2.6.3 Qiagen Laboratory Developed Tests (LDT) Product and Solutions
    • 2.6.4 Qiagen Laboratory Developed Tests (LDT) Revenue, Gross Margin and Market Share (2020-2025)
    • 2.6.5 Qiagen Recent Developments and Future Plans
  • 2.7 Eurofins
    • 2.7.1 Eurofins Details
    • 2.7.2 Eurofins Major Business
    • 2.7.3 Eurofins Laboratory Developed Tests (LDT) Product and Solutions
    • 2.7.4 Eurofins Laboratory Developed Tests (LDT) Revenue, Gross Margin and Market Share (2020-2025)
    • 2.7.5 Eurofins Recent Developments and Future Plans
  • 2.8 Guardant Health
    • 2.8.1 Guardant Health Details
    • 2.8.2 Guardant Health Major Business
    • 2.8.3 Guardant Health Laboratory Developed Tests (LDT) Product and Solutions
    • 2.8.4 Guardant Health Laboratory Developed Tests (LDT) Revenue, Gross Margin and Market Share (2020-2025)
    • 2.8.5 Guardant Health Recent Developments and Future Plans
  • 2.9 Adaptive Biotechnologies
    • 2.9.1 Adaptive Biotechnologies Details
    • 2.9.2 Adaptive Biotechnologies Major Business
    • 2.9.3 Adaptive Biotechnologies Laboratory Developed Tests (LDT) Product and Solutions
    • 2.9.4 Adaptive Biotechnologies Laboratory Developed Tests (LDT) Revenue, Gross Margin and Market Share (2020-2025)
    • 2.9.5 Adaptive Biotechnologies Recent Developments and Future Plans
  • 2.10 Biodesix
    • 2.10.1 Biodesix Details
    • 2.10.2 Biodesix Major Business
    • 2.10.3 Biodesix Laboratory Developed Tests (LDT) Product and Solutions
    • 2.10.4 Biodesix Laboratory Developed Tests (LDT) Revenue, Gross Margin and Market Share (2020-2025)
    • 2.10.5 Biodesix Recent Developments and Future Plans
  • 2.11 Berry Oncology
    • 2.11.1 Berry Oncology Details
    • 2.11.2 Berry Oncology Major Business
    • 2.11.3 Berry Oncology Laboratory Developed Tests (LDT) Product and Solutions
    • 2.11.4 Berry Oncology Laboratory Developed Tests (LDT) Revenue, Gross Margin and Market Share (2020-2025)
    • 2.11.5 Berry Oncology Recent Developments and Future Plans
  • 2.12 Genetron Health
    • 2.12.1 Genetron Health Details
    • 2.12.2 Genetron Health Major Business
    • 2.12.3 Genetron Health Laboratory Developed Tests (LDT) Product and Solutions
    • 2.12.4 Genetron Health Laboratory Developed Tests (LDT) Revenue, Gross Margin and Market Share (2020-2025)
    • 2.12.5 Genetron Health Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global Laboratory Developed Tests (LDT) Revenue and Share by Players (2020-2025)
  • 3.2 Market Share Analysis (2024)
    • 3.2.1 Market Share of Laboratory Developed Tests (LDT) by Company Revenue
    • 3.2.2 Top 3 Laboratory Developed Tests (LDT) Players Market Share in 2024
    • 3.2.3 Top 6 Laboratory Developed Tests (LDT) Players Market Share in 2024
  • 3.3 Laboratory Developed Tests (LDT) Market: Overall Company Footprint Analysis
    • 3.3.1 Laboratory Developed Tests (LDT) Market: Region Footprint
    • 3.3.2 Laboratory Developed Tests (LDT) Market: Company Product Type Footprint
    • 3.3.3 Laboratory Developed Tests (LDT) Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global Laboratory Developed Tests (LDT) Consumption Value and Market Share by Type (2020-2025)
  • 4.2 Global Laboratory Developed Tests (LDT) Market Forecast by Type (2026-2031)

5 Market Size Segment by Application

  • 5.1 Global Laboratory Developed Tests (LDT) Consumption Value Market Share by Application (2020-2025)
  • 5.2 Global Laboratory Developed Tests (LDT) Market Forecast by Application (2026-2031)

6 North America

  • 6.1 North America Laboratory Developed Tests (LDT) Consumption Value by Type (2020-2031)
  • 6.2 North America Laboratory Developed Tests (LDT) Market Size by Application (2020-2031)
  • 6.3 North America Laboratory Developed Tests (LDT) Market Size by Country
    • 6.3.1 North America Laboratory Developed Tests (LDT) Consumption Value by Country (2020-2031)
    • 6.3.2 United States Laboratory Developed Tests (LDT) Market Size and Forecast (2020-2031)
    • 6.3.3 Canada Laboratory Developed Tests (LDT) Market Size and Forecast (2020-2031)
    • 6.3.4 Mexico Laboratory Developed Tests (LDT) Market Size and Forecast (2020-2031)

7 Europe

  • 7.1 Europe Laboratory Developed Tests (LDT) Consumption Value by Type (2020-2031)
  • 7.2 Europe Laboratory Developed Tests (LDT) Consumption Value by Application (2020-2031)
  • 7.3 Europe Laboratory Developed Tests (LDT) Market Size by Country
    • 7.3.1 Europe Laboratory Developed Tests (LDT) Consumption Value by Country (2020-2031)
    • 7.3.2 Germany Laboratory Developed Tests (LDT) Market Size and Forecast (2020-2031)
    • 7.3.3 France Laboratory Developed Tests (LDT) Market Size and Forecast (2020-2031)
    • 7.3.4 United Kingdom Laboratory Developed Tests (LDT) Market Size and Forecast (2020-2031)
    • 7.3.5 Russia Laboratory Developed Tests (LDT) Market Size and Forecast (2020-2031)
    • 7.3.6 Italy Laboratory Developed Tests (LDT) Market Size and Forecast (2020-2031)

8 Asia-Pacific

  • 8.1 Asia-Pacific Laboratory Developed Tests (LDT) Consumption Value by Type (2020-2031)
  • 8.2 Asia-Pacific Laboratory Developed Tests (LDT) Consumption Value by Application (2020-2031)
  • 8.3 Asia-Pacific Laboratory Developed Tests (LDT) Market Size by Region
    • 8.3.1 Asia-Pacific Laboratory Developed Tests (LDT) Consumption Value by Region (2020-2031)
    • 8.3.2 China Laboratory Developed Tests (LDT) Market Size and Forecast (2020-2031)
    • 8.3.3 Japan Laboratory Developed Tests (LDT) Market Size and Forecast (2020-2031)
    • 8.3.4 South Korea Laboratory Developed Tests (LDT) Market Size and Forecast (2020-2031)
    • 8.3.5 India Laboratory Developed Tests (LDT) Market Size and Forecast (2020-2031)
    • 8.3.6 Southeast Asia Laboratory Developed Tests (LDT) Market Size and Forecast (2020-2031)
    • 8.3.7 Australia Laboratory Developed Tests (LDT) Market Size and Forecast (2020-2031)

9 South America

  • 9.1 South America Laboratory Developed Tests (LDT) Consumption Value by Type (2020-2031)
  • 9.2 South America Laboratory Developed Tests (LDT) Consumption Value by Application (2020-2031)
  • 9.3 South America Laboratory Developed Tests (LDT) Market Size by Country
    • 9.3.1 South America Laboratory Developed Tests (LDT) Consumption Value by Country (2020-2031)
    • 9.3.2 Brazil Laboratory Developed Tests (LDT) Market Size and Forecast (2020-2031)
    • 9.3.3 Argentina Laboratory Developed Tests (LDT) Market Size and Forecast (2020-2031)

10 Middle East & Africa

  • 10.1 Middle East & Africa Laboratory Developed Tests (LDT) Consumption Value by Type (2020-2031)
  • 10.2 Middle East & Africa Laboratory Developed Tests (LDT) Consumption Value by Application (2020-2031)
  • 10.3 Middle East & Africa Laboratory Developed Tests (LDT) Market Size by Country
    • 10.3.1 Middle East & Africa Laboratory Developed Tests (LDT) Consumption Value by Country (2020-2031)
    • 10.3.2 Turkey Laboratory Developed Tests (LDT) Market Size and Forecast (2020-2031)
    • 10.3.3 Saudi Arabia Laboratory Developed Tests (LDT) Market Size and Forecast (2020-2031)
    • 10.3.4 UAE Laboratory Developed Tests (LDT) Market Size and Forecast (2020-2031)

11 Market Dynamics

  • 11.1 Laboratory Developed Tests (LDT) Market Drivers
  • 11.2 Laboratory Developed Tests (LDT) Market Restraints
  • 11.3 Laboratory Developed Tests (LDT) Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 Laboratory Developed Tests (LDT) Industry Chain
  • 12.2 Laboratory Developed Tests (LDT) Upstream Analysis
  • 12.3 Laboratory Developed Tests (LDT) Midstream Analysis
  • 12.4 Laboratory Developed Tests (LDT) Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Laboratory Developed Tests (LDT) market size was valued at US$ 5942 million in 2024 and is forecast to a readjusted size of USD 10930 million by 2031 with a CAGR of 9.1% during review period.
    Laboratory development testing refers to preliminary tests or tests in the development phase conducted in a laboratory environment to evaluate the feasibility, performance and stability of new products, technologies or solutions. LDT is usually carried out during the research and development of products or technologies to verify design concepts, optimize process flows, or test their basic functions and technical parameters under controlled experimental conditions. Through these experiments, researchers can identify potential problems and make adjustments, laying the foundation for subsequent prototyping, industrial production or larger-scale application testing. LDT usually focuses on the exploration of technical details, material properties, system integration, etc. to ensure that the final product can meet the expected standards and requirements.
    Laboratory development testing (LDT) plays a vital role in the process of technology and product development. It is not only a key step in verifying theoretical design, but also an experimental and adjustment link in the innovation process. Through LDT, the R&D team can observe the actual performance of new technologies in detail in a controlled experimental environment, identify potential defects and optimization space, and thus provide data support and theoretical basis for the large-scale production of products. The core advantage of LDT is that it provides developers with an efficient, safe and low-cost platform to quickly iterate and optimize designs without the risk of large-scale production. Although the results of LDT may not fully predict the performance of the final product in actual applications, it provides a valuable reference for decision-making throughout the development cycle, helping the team to make more accurate technical adjustments and improvements. Therefore, LDT is not only the basis for product development, but also an important driving force for innovation and technological breakthroughs.Global top 5 players of Laboratory Developed Tests (LDT) occupied for 53% of the market, including Quest Diagnostics, Thermo Fisher, Waters Corporation, Roche, Illumina. North America is the largest market of Laboratory Developed Tests (LDT), holding a share over 47%. Then Europe takes 25%. In terms of type, Molecular Diagnostics shares over 31% of the market, while Immunology shares 25%. In terms of application, Hospitals Laboratory shares the largest percent of nearly 56%.Companies that provide laboratory developed testing (LDT) services should focus on improving their technical strength and innovation capabilities in the competition to ensure that they can provide high-quality, customized test solutions to meet the needs of different customers. Companies should increase R&D investment and continuously introduce advanced equipment and technologies to improve the accuracy and reliability of experiments. At the same time, optimizing the test process and improving efficiency will help shorten the development cycle and reduce customers' time and cost pressures. In addition, focusing on close cooperation with customers and providing professional technical support and consulting services can provide customers with more valuable solutions and improve customer satisfaction and loyalty. Strengthen market positioning, focus on specific industries or technical fields, and enhance influence and professionalism in this field by building brand reputation and accumulating cases, so as to gain advantages in the highly competitive market.
    This report is a detailed and comprehensive analysis for global Laboratory Developed Tests (LDT) market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Laboratory Developed Tests (LDT) market size and forecasts, in consumption value ($ Million), 2020-2031
    Global Laboratory Developed Tests (LDT) market size and forecasts by region and country, in consumption value ($ Million), 2020-2031
    Global Laboratory Developed Tests (LDT) market size and forecasts, by Type and by Application, in consumption value ($ Million), 2020-2031
    Global Laboratory Developed Tests (LDT) market shares of main players, in revenue ($ Million), 2020-2025
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Laboratory Developed Tests (LDT)
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Laboratory Developed Tests (LDT) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Quest Diagnostics, Thermo Fisher, Waters Corporation, Roche, Illumina, Qiagen, Eurofins, Guardant Health, Adaptive Biotechnologies, Biodesix, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    Laboratory Developed Tests (LDT) market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Clinical Biochemistry
    Hematology
    Immunology
    Molecular Diagnostics
    Other
    Market segment by Application
    Hospitals Laboratory
    Clinical Research Organizations
    Academic Institutes
    Specialty Diagnostic Centers
    Other
    Market segment by players, this report covers
    Quest Diagnostics
    Thermo Fisher
    Waters Corporation
    Roche
    Illumina
    Qiagen
    Eurofins
    Guardant Health
    Adaptive Biotechnologies
    Biodesix
    Berry Oncology
    Genetron Health
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe Laboratory Developed Tests (LDT) product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of Laboratory Developed Tests (LDT), with revenue, gross margin, and global market share of Laboratory Developed Tests (LDT) from 2020 to 2025.
    Chapter 3, the Laboratory Developed Tests (LDT) competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2020 to 2031
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2020 to 2025.and Laboratory Developed Tests (LDT) market forecast, by regions, by Type and by Application, with consumption value, from 2026 to 2031.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of Laboratory Developed Tests (LDT).
    Chapter 13, to describe Laboratory Developed Tests (LDT) research findings and conclusion.

    Buy now